PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22816446-1	2012	BACKGROUND: Delayed hypersensitivity (HS) reactions to potentiated sulfonamide antimicrobials occur in both dogs and humans, and involve an intermediate hydroxylamine metabolite that is detoxified by cytochrome b(5) and NADH cytochrome b(5) reductase.	Hydroxylamine	153-166	cytochrome b5 type A	Homo sapiens	200-215	
2835106-3	1988	This inactivation of cytochrome b5 is reversed with hydroxylamine, which also suggests but does not prove histidine involvement.	Hydroxylamine	52-65	cytochrome b5 type A	Homo sapiens	21-34	
22816446-1	2012	BACKGROUND: Delayed hypersensitivity (HS) reactions to potentiated sulfonamide antimicrobials occur in both dogs and humans, and involve an intermediate hydroxylamine metabolite that is detoxified by cytochrome b(5) and NADH cytochrome b(5) reductase.	Hydroxylamine	153-166	cytochrome b5 type A	Homo sapiens	225-240	
17622936-0	2007	Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity.	Hydroxylamine	82-95	cytochrome b5 type A	Homo sapiens	36-49	
19997042-0	2010	Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.	Hydroxylamine	84-97	cytochrome b5 type A	Homo sapiens	0-13	
19997042-0	2010	Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.	Hydroxylamine	84-97	cytochrome b5 type A	Homo sapiens	23-36	
19997042-10	2010	CONCLUSION: These studies indicate that although novel cSNPs in CYB5A and CYB5R3 are associated with significantly altered protein expression and/or hydroxylamine reduction activities, these low-frequency cSNPs seem to only minimally impact overall observed phenotypic variability.	Hydroxylamine	149-162	cytochrome b5 type A	Homo sapiens	64-69	
17622936-10	2007	CONCLUSIONS: These data indicate that a naturally occurring variant in cyt b5, T60A, leads to modestly altered affinity for hydroxylamine substrates and dramatically reduced cyt b5 expression.	Hydroxylamine	124-137	cytochrome b5 type A	Homo sapiens	71-77	
23045123-2	2005	In addition, b(5)R and cyt b(5) can directly catalyze the reduction of hydroxylamine and amidoxime metabolites.	Hydroxylamine	71-84	cytochrome b5 type A	Homo sapiens	23-31